Stockreport

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023 [Yahoo! Finance]

INTEGRATED BIOPHARMA INC  (INBP) 
US:NASDAQ Investor Relations: ibiopharma.com
PDF Revenue for the quarter ended December 31, 2023 was $11.5 million compared to $12.3 million for the quarter ended December 31, 2022, a decrease of $0.8 million or 6.5%. [Read more]